In order to assess the biological role of the flap endonuclease 1 (Fen1), RNA interference (RNAi) was chosen as a method for FEN1 down-regulation in this study. Knock down of FEN1 was achieved both in stable transfected HeLa cells, using vector-based method, and by transient transfection using siRNAs. For transient assays, knock down was monitored by the down regulation of green fluorescence protein (GFP) expression, the GFP gene was fused with the Fen1 gene. In the vector-based method, knock down of FEN1 was monitored by Western analysis. HeLa cells deficient for FEN1 expression was investigated for phenotypical changes such as growth retardation and sensitivity to DNA damaging agents. Findings indicated that HeLa cells deficient in FEN1 ...
Flap structure-specific endonuclease 1 (FEN1) is one of the enzymes that involve in Eukaryotic DNA r...
AbstractDNA flap endonuclease 1 (FEN1) plays critical roles in maintaining genome stability and inte...
Synthetic lethal strategies for cancer therapeutics seek to target genetic defects or vulnerabilitie...
<div><p>Flap endonuclease 1 (FEN1) is a structure selective endonuclease required for proficient DNA...
<p>(A) Depletion of FEN1 mitigates DNA damage and cell death resulting from hWH knockdown in human c...
The conserved, structure-specific flap endonuclease FEN1 cleaves 5' DNA flaps that arise during repl...
The flap endonuclease, FEN1, is an evolutionarily conserved component of DNA replication from archae...
AbstractIt has been shown that flap endonuclease-1 (FEN-1), a structure-specific nuclease, acts on t...
The structure specific flap endonuclease 1 (FEN1) plays an essential role in long-patch base excisio...
<p>(A) siRNA-mediated knockdown of FEN1 selectively inhibits the proliferation of <i>CDC4</i>-knocko...
Synthetic lethality strategies for cancer therapy exploit cancer-specific genetic defects to identif...
Flap endonuclease 1 (FEN1) is an essential enzyme that removes RNA primers and base lesions during D...
Flap endonuclease 1 (FEN1) is an essential enzyme that removes RNA primers and base lesions during D...
Flap Endonuclease 1 (FEN1) is a structure-specific nuclease fundamental for DNA replication and repa...
Flap endonuclease 1 (FEN1) is a paradigm of structure-specific metallonuclease family that selective...
Flap structure-specific endonuclease 1 (FEN1) is one of the enzymes that involve in Eukaryotic DNA r...
AbstractDNA flap endonuclease 1 (FEN1) plays critical roles in maintaining genome stability and inte...
Synthetic lethal strategies for cancer therapeutics seek to target genetic defects or vulnerabilitie...
<div><p>Flap endonuclease 1 (FEN1) is a structure selective endonuclease required for proficient DNA...
<p>(A) Depletion of FEN1 mitigates DNA damage and cell death resulting from hWH knockdown in human c...
The conserved, structure-specific flap endonuclease FEN1 cleaves 5' DNA flaps that arise during repl...
The flap endonuclease, FEN1, is an evolutionarily conserved component of DNA replication from archae...
AbstractIt has been shown that flap endonuclease-1 (FEN-1), a structure-specific nuclease, acts on t...
The structure specific flap endonuclease 1 (FEN1) plays an essential role in long-patch base excisio...
<p>(A) siRNA-mediated knockdown of FEN1 selectively inhibits the proliferation of <i>CDC4</i>-knocko...
Synthetic lethality strategies for cancer therapy exploit cancer-specific genetic defects to identif...
Flap endonuclease 1 (FEN1) is an essential enzyme that removes RNA primers and base lesions during D...
Flap endonuclease 1 (FEN1) is an essential enzyme that removes RNA primers and base lesions during D...
Flap Endonuclease 1 (FEN1) is a structure-specific nuclease fundamental for DNA replication and repa...
Flap endonuclease 1 (FEN1) is a paradigm of structure-specific metallonuclease family that selective...
Flap structure-specific endonuclease 1 (FEN1) is one of the enzymes that involve in Eukaryotic DNA r...
AbstractDNA flap endonuclease 1 (FEN1) plays critical roles in maintaining genome stability and inte...
Synthetic lethal strategies for cancer therapeutics seek to target genetic defects or vulnerabilitie...